Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323595 · ClinicalTrials.gov registry record · NA
Effectiveness of Celecoxib After Surgical Sperm Retrieval
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01323595 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 78 participants.
The verdict
NCT01323595, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
While narcotic medication are commonly used for pain control near the time of surgery, there are significant side effects including constipation, nausea, risk of overdose leading to decreased breathing, and risk of addiction to narcotics. Our goal is to explore alternatives to narcotics for perioperative pain for patients undergoing sperm retrieval surgery. We have designed a prospective randomized clinical trial to evaluate how effective the anti-inflammatory medicine celecoxib(Celebrex©) is for pain control near the time of surgery. Celecoxib is known as a COX-2 inhibitor, a drug that belongs to the non-steroidal anti-inflammatory drug (NSAID) class. It is used to reduce swelling and to treat pain. Patients will be divided into two groups: the first group receives a celecoxib pill and the second group receives a sugar pill(placebo). Patients and doctors will be unaware of exactly which pills are given. The patient will complete questionnaires for pain level. By comparing the pain levels we can better understand whether celecoxib (Celebrex©) significantly decreases perioperative pain.
Interventions
- DRUG Celecoxib
- DRUG Sugar Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01323595
The ClinicalTrials.gov registry entry for NCT01323595 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Celecoxib is the first listed.
NCT01323595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01323595 about?
NCT01323595 is a clinical study titled "Effectiveness of Celecoxib After Surgical Sperm Retrieval". While narcotic medication are commonly used for pain control near the time of surgery, there are significant side effects including constipation, nausea, risk of overdose leading to decreased breathing, and risk of addiction to narcotics. Our goal is to explore alternatives to narcotics for perioper...
What is the current status of trial NCT01323595?
This trial is currently terminated. It is a NA study. The enrollment target is 78 participants. The study started on 2011-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01323595?
The interventions under investigation include: Celecoxib (DRUG), Sugar Pill (DRUG).
Who is sponsoring clinical trial NCT01323595?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.